a-MSH, amide: Mechanistic and Applied Insights for Pigmentat
a-MSH, amide: Mechanistic and Applied Insights for Pigmentation Research
Executive Summary: a-MSH, amide (Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2) is a synthetic melanocortin peptide derived from pro-opiomelanocortin (POMC), pivotal for melanogenesis modeling in vitro (source: product_spec). It increases pigmentation by binding to MC1R on melanocytes, stimulating melanin synthesis and offering an established model for pigmentation regulation research (source: workflow_recommendation). The peptide also modulates inflammatory responses via peripheral and central pathways, supporting anti-inflammatory peptide research (source: paper). a-MSH, amide is highly water-soluble (≥10.44 mg/mL) and DMSO-soluble (≥166.5 mg/mL), but ethanol-insoluble, enabling robust assay flexibility (source: product_spec). APExBIO supplies this reagent for reproducible cell and receptor-based studies, with protocol recommendations for optimal storage and use (source: workflow_recommendation).
Biological Rationale
a-MSH, amide is a synthetic analogue of the endogenous alpha-melanocyte-stimulating hormone (α-MSH), a peptide hormone released from pro-opiomelanocortin (POMC) processing in the pituitary and peripheral tissues (source: product_spec). Endogenous α-MSH regulates melanocyte differentiation and activity, primarily increasing melanin production for photoprotection and skin tone modulation (source: paper). Melanin content and distribution are core determinants of pigmentation phenotype in mammals. Disruptions in melanin synthesis or transport result in hyperpigmentation disorders, including freckles, chloasma, and senile plaques (source: paper).
In addition, α-MSH exerts anti-inflammatory effects on both immune and glial cells, acting through melanocortin receptors (MC1R and MC3R) to modulate cytokine secretion and oxidative stress (source: workflow_recommendation). These properties make a-MSH, amide an indispensable tool in pigmentation regulation research and anti-inflammatory peptide research.
Mechanism of Action of a-MSH, amide
a-MSH, amide functions as a melanocortin receptor agonist, with high affinity for MC1R on melanocytes (source: product_spec). Receptor activation increases intracellular cAMP levels, triggering phosphorylation of CREB (cyclic AMP response element-binding protein), and upregulation of microphthalmia-associated transcription factor (MITF) (source: paper). MITF, in turn, directly activates the transcription of key melanogenic enzymes: tyrosinase (TYR), TYRP1, and TYRP2, resulting in increased melanin biosynthesis (source: paper).
Beyond melanogenesis, a-MSH, amide engages anti-inflammatory pathways by inhibiting nitric oxide (NO) production in activated macrophages and reducing pro-inflammatory cytokine release (source: paper). These dual actions underpin its wide adoption in melanin synthesis modulation and inflammation studies.
Evidence & Benchmarks
- α-MSH stimulation of B16F10 melanoma cells significantly increases cellular melanin content and tyrosinase activity in a dose-dependent manner (source: paper).
- α-MSH upregulates MITF gene and protein expression, linking MC1R activation to transcriptional control of melanogenic enzymes (source: paper).
- a-MSH, amide from APExBIO is water-soluble at ≥10.44 mg/mL (with ultrasonication) and DMSO-soluble at ≥166.5 mg/mL (with gentle warming), but is insoluble in ethanol (source: product_spec).
- Anti-inflammatory activity of α-MSH is demonstrated by a reduction in LPS-induced nitric oxide (NO) production in RAW264.7 macrophages (source: paper).
- GRE (glabridin, resveratrol, ellagic acid) combination suppresses α-MSH-induced melanogenesis via CREB/MITF pathway inhibition, confirming the central role of this axis in pigmentation disorders (source: workflow_recommendation).
- APExBIO's a-MSH, amide (SKU A1025) is validated for use in cell-based pigmentation and anti-inflammatory workflows (source: workflow_recommendation).
Compared to "a-MSH, amide: Mechanisms, Assay Optimization & Translational Impact", which focuses on the nuances of assay design and translational impact, this article consolidates mechanistic, benchmarking, and workflow integration with a focus on anti-inflammatory and pigmentation disorder applications. For protocol optimization and troubleshooting, see "Applied a-MSH, amide Workflows for Pigmentation Research"; here, we emphasize evidence synthesis and mechanistic context.
Applications, Limits & Misconceptions
a-MSH, amide is widely applied in research on pigmentation disorders and melanin synthesis modulation. Its anti-inflammatory effects extend its use to studies of neurogenic and peripheral inflammation. It is also employed in high-throughput GPCR ligand screening and mechanistic dissection of melanocortin signaling (source: workflow_recommendation).
Common Pitfalls or Misconceptions
- Not a direct skin lightener: a-MSH, amide increases, not decreases, melanin synthesis; it is not suitable for direct clinical depigmentation (source: paper).
- Not stable in solution for long-term storage: All working solutions should be freshly prepared; long-term storage leads to peptide degradation (source: product_spec).
- Activity is receptor-context dependent: Effects are mediated via specific melanocortin receptors (primarily MC1R); results may differ in receptor-deficient models (source: workflow_recommendation).
- Insoluble in ethanol: Attempting to dissolve a-MSH, amide in ethanol results in precipitation and sample loss (source: product_spec).
- Not a broad-spectrum anti-inflammatory agent: Its effects are specific to certain inflammatory pathways and cell types (source: paper).
Workflow Integration & Parameters
a-MSH, amide (APExBIO, SKU A1025) is formulated as a solid for reconstitution prior to use. Below are key protocol parameters for pigmentation and inflammation research:
Protocol Parameters
- assay: melanogenesis induction | value_with_unit: 10–100 nM, 24–72 h | applicability: B16F10 or primary melanocyte cultures | rationale: Dose range supports robust melanin/tyrosinase response without cytotoxicity | source_type: paper (link)
- assay: anti-inflammatory response | value_with_unit: 10–100 nM, 24 h | applicability: RAW264.7 macrophage NO inhibition | rationale: Matches reported dose for significant NO reduction | source_type: paper (link)
- assay: peptide dissolution in water | value_with_unit: ≥10.44 mg/mL (ultrasonication recommended) | applicability: all in vitro workflows | rationale: Ensures full solubility for reproducible dosing | source_type: product_spec (link)
- assay: peptide dissolution in DMSO | value_with_unit: ≥166.5 mg/mL (gentle warming) | applicability: high-throughput screening or low-volume dosing | rationale: High solubility allows stock preparation for screening | source_type: product_spec (link)
- assay: storage | value_with_unit: -20°C (solid) | applicability: all formats | rationale: Maintains peptide integrity | source_type: product_spec (link)
- assay: solution stability | value_with_unit: use immediately after preparation | applicability: all in vitro/in vivo use | rationale: Solutions degrade rapidly; avoid long-term storage | source_type: workflow_recommendation (link)
For advanced assay troubleshooting and translational workflow development, see "a-MSH, amide: Applied Protocols for Pigmentation Regulation Research", which provides actionable protocol adaptations. This article integrates mechanistic rationale and validated benchmarks across research domains.
Conclusion & Outlook
a-MSH, amide (APExBIO SKU A1025) is a validated, mechanistically precise tool for pigmentation regulation and anti-inflammatory peptide research. It is indispensable for dissecting the CREB/MITF axis and modeling melanin synthesis in cell-based platforms. Data confirm its solubility, stability requirements, and cell-type specificity (source: product_spec). As research on hyperpigmentation disorders and anti-melanogenic interventions advances, a-MSH, amide remains the gold standard for pathway interrogation and assay calibration (source: paper). Future studies should focus on refining dose-response relationships and extending mechanistic insights to translational models (workflow_recommendation).